Wolfe v. Enochian BioSciences Denmark ApS

District Court, D. Vermont·Decided July 1, 2022·No. 2:21-cv-00053·Unknown

Opinion

UNITED STATES DISTRICT COURT reed FOR THE 2022 JUL -! □□□□ 10 DISTRICT OF VERMONT CLERK ROBERT WOLFE ) py □□□ and CROSSFIELD, INC., ) DEPUTY CLERK Plaintiffs, Vv. Case No. 2:21-cv-00053 ENOCHIAN BIOSCIENCES DENMARK APS, RENE SINDLEV, LUISA PUCHE, and) ENOCHIAN BIOSCIENCES, INC., ) Defendants.

ENTRY ORDER GRANTING IN PART AND DENYING IN PART DEFENDANTS’ MOTION FOR A PROTECTIVE ORDER (Doc. 58) Plaintiffs Robert Wolfe and Crossfield, Inc. bring this malicious prosecution action against Defendants Enochian BioSciences Denmark ApS (“Enochian Denmark”), Enochian BioSciences, Inc. (“Enochian BioSciences” and, together with Enochian Denmark, “Enochian’’), René Sindlev, and Luisa Puche (collectively, “Defendants”). Pending before the court is Defendants’ June 3, 2022 motion for a protective order to prevent disclosure of allegedly confidential and proprietary information. (Doc. 58.) On June 9, 2022, Plaintiffs filed their opposition and Defendants replied on June 10, 2022, at which time the court took the pending motion under advisement Plaintiffs are represented by Daniel D. McCabe, Esq. Defendants are represented by Christopher J. Valente, Esq., Michael R. Creta, Esq., and David M. Pocius, Esq. I. Factual and Procedural Background. On May 10, 2022, Plaintiffs served 67 interrogatories and 30 document requests on Defendants. Defendants argue these requests seek “sensitive financial information, company meeting minutes and resolutions, electronic records dating back to 2018, information concerning top Enochian executives and board members, and the details of

internal Enochian decision-making processes and strategies.” (Doc. 58 at 2.) Plaintiffs also seek information pertaining to Serhat Gumrukcu, a founder of Enochian who was indicted for murder in this District in May 2022. Plaintiffs’ interrogatories relate to Defendants’ knowledge regarding previous criminal charges against Mr. Gumrukcu, security services provided to him by Defendants; “any efforts taken to conceal [his] security when he has been visible in public”; and “any disagreements or disputes that arose between Defendants and Plaintiffs regarding” payments to him. (Doc. 58-2 at 10.) Plaintiffs intend to depose Ms. Puche, Chief Financial Officer and Corporate Secretary for Enochian BioSciences; Mr. Sindlev, Chairman of Enochian BioScience’s Board of Directors; and corporate representatives from both Enochian Denmark and Enochian BioSciences. The depositions will cover topics including “facts and opinions regarding [Enochian’s] allegedly confidential information.” (Doc. 58 at 2.) While Defendants argue that “many” of Plaintiffs discovery requests “have little to no relevance to this Action[,]” they do not move for a protective order to preclude any discovery. Jd. at 1. Rather, Defendants seek only to shield certain information produced during discovery from public view. Defendants argue that Plaintiffs’ discovery requests “threatens to unnecessarily disclose confidential, proprietary Enochian information,” (Doc. 58 at 4), such as “research and development initiatives, product development pipelines, key business strategies, and compensation issues” as well as “confidential terms in [insurance] policies.” (Doc. 63 at 2-3.) They propose a protective order that allows parties to designate materials produced in discovery as confidential with protections against their disclosure. Plaintiffs contend that the discovery sought is limited to “information about why they were terminated, why a [lawsuit] was brought against them in Vermont, and who made the decisions” and does not seek trade secrets or any other confidential information that would put Defendants at a market disadvantage. (Doc 62 at 3.) Plaintiffs assert that a protective order would only invite discovery disputes as Defendants would “improperly classify expansive categories of information ‘confidential,’” as they allegedly did in the underlying state court action which is the subject of this case. Jd. at 2.

II. Conclusions of Law and Analysis. “The court may, for good cause, issue an order to protect a party or person from annoyance, embarrassment, oppression, or undue burden or expense[.]” Fed. R. Civ. P. 26(c)(1). “The party seeking a protective order has the burden of showing that good cause exists for issuance of that order.” Gambale v. Deutsche Bank AG, 377 F.3d 133, 142 (2d Cir. 2004) (citation omitted). “[A] showing of good cause does not require specific or concrete factual showings of harm. Broader allegations typically suffice.” Jenkins v. Miller, 2019 WL 5558601, at *7 (D. Vt. Oct. 29, 2019) (citing Penthouse International, Ltd. v. Playboy Enterprises, Inc., 663 F.2d 371, 391 (2d Cir. 1981); Dove v. Atlantic Capital Corp., 963 F.2d 15, 18-20 (2d Cir. 1992)). While the court must “weigh fairly the competing needs and interests of parties affected by discovery[,]” it has “substantial latitude to fashion protective orders[,]” Seattle Times Co. v. Rhinehart, 467 U.S. 20, 36 (1984), and “manage the discovery process.” EM Ltd. v. Republic of Argentina, 695 F.3d 201, 207 (2d Cir. 2012). Restrictions on disclosure of confidential or sensitive commercial information are “a routine feature of civil litigation[.]” Jn re The City of New York, 607 F.3d 923, 935 (2d Cir. 2010); see also Fed. Open Mkt. Comm. of Fed. Rsrv. Sys. v. Merrill, 443 U.S. 340, 362 (1979) (noting that “confidential commercial information” is “{f]requently” “afforded a limited protection” in civil discovery) (internal quotation marks and citations omitted). The Federal Rules of Civil Procedure authorize limitations on how “trade secret or other confidential research, development, or commercial information” may be “revealed{.]” Fed. R. Civ. P. 26(c)(1)(G). “Protective orders serve the vital function of securing the just, speedy, and inexpensive determination of civil disputes by encouraging full disclosure of all evidence that might conceivably be relevant. This objective represents the cornerstone of our administration of civil justice.” Kiobel by Samkalden v. Cravath, Swaine & Moore LLP, 895 F.3d 238, 247 (2d Cir. 2018) (alterations adopted) (internal quotation marks omitted) (citing S.E.C. v. TheStreet.Com, 273 F.3d 222, 229 (2d Cir. 2001)). Courts in the Second Circuit have regularly issued protective orders limiting

public disclosure of the type of information at issue. See, e.g., Mitchell v. Metro. Life Ins. Co., 2004 WL 2439704, at *2 (S.D.N.Y. Nov. 2, 2004) (issuing protective order for personnel files and “internal financial analyses, business plans and other sensitive company information”); Garnett-Bishop v. New York Cmty. Bancorp, Inc., 2013 WL 101590, at *2 (E.D.N.Y. Jan. 8, 2013) (collecting cases protecting personnel files and internal corporate documents).

Free access — add to your briefcase to read the full text and ask questions with AI

Wolfe v. Enochian BioSciences Denmark ApS, (D. Vt. 2022).

Wolfe v. Enochian BioSciences Denmark ApS (Wolfe v. Enochian BioSciences Denmark ApS) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Seattle Times Co. v. Rhinehart
467 U.S. 20 (Supreme Court, 1984)
In re The City of New York
607 F.3d 923 (Second Circuit, 2010)
NML Capital, Ltd. v. Republic of Argentina
695 F.3d 201 (Second Circuit, 2012)
Kiobel v. Cravath, Swaine & Moore LLP
895 F.3d 238 (Second Circuit, 2018)